Lantheus Holdings (LNTH) Capital Expenditures Growth (1y) (2015 - 2026)
Lantheus Holdings (LNTH) Capital Expenditures Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn | 32.28% |
| 3 | Zoetis | 32.67 Bn | 30.73 Bn | 1.62 Bn | -38.20% |
| 4 | Takeda Pharmaceutical | 27.69 Bn | 23.63 Bn | 4.39 Bn | -15.72% |
| 5 | United Therapeutics | 23.12 Bn | 20.97 Bn | 648.10 Mn | 32.98% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.24 Bn | 18.44 Bn | 1.16 Bn | -6.34% |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn | -86.92% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.22 Bn | 785.00 Mn | -21.54% |
| 10 | Lantheus Holdings | 6.96 Bn | 6.46 Bn | 230.92 Mn | -44.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.90% |
| Dec 31, 2025 | 140.57% |
| Sep 30, 2025 | -88.69% |
| Jun 30, 2025 | -121.64% |
| Mar 31, 2025 | -14.56% |
| Dec 31, 2024 | -97.70% |
| Sep 30, 2024 | 84.46% |
| Jun 30, 2024 | 136.89% |
| Mar 31, 2024 | -18.83% |
| Dec 31, 2023 | -309.12% |
| Sep 30, 2023 | 438.25% |
| Jun 30, 2023 | 163.00% |
| Mar 31, 2023 | 164.67% |
| Dec 31, 2022 | 51.13% |
| Dec 31, 2021 | 239.72% |
| Dec 31, 2020 | 33.90% |
| Sep 30, 2020 | 11.99% |
| Jun 30, 2020 | -34.33% |
| Mar 31, 2020 | -74.43% |
| Dec 31, 2019 | -278.46% |